Ankylosing Spondylitis: Symptoms, Systemic Impact, and the Critical Importance of Early Diagnosis

Ankylosing spondylitis (AS) is a chronic inflammatory arthritis primarily targeting the spine and sacroiliac (SI) joints—the junction where the spine meets the pelvis. Over time, inflammation drives new bone formation (syndesmophytes), potentially fusing vertebrae into a rigid "bamboo spine." But AS is not just a back disease—it's a systemic condition that can affect eyes, heart, lungs, and peripheral joints.

Spinal Manifestations

  • Inflammatory back pain: Insidious onset <45 years, >3 months duration, improves with exercise (not rest), worse at night/early morning, alternates buttock pain.
  • Progressive stiffness: Loss of spinal mobility—lumbar, then thoracic, then cervical.
  • Vertebral fusion: Advanced disease → fixed kyphosis, reduced chest expansion, impaired mobility.

Extra-Spinal Manifestations

  • Peripheral arthritis: Hips, knees, shoulders—often asymmetric, large joints.
  • Enthesitis: Inflammation at tendon/ligament insertions (Achilles, plantar fascia, costochondral).
  • Acute Anterior Uveitis (AAU): 25–40% lifetime risk. Sudden eye pain, redness, photophobia, blurred vision. Ophthalmologic emergency—treat within 24h to prevent vision loss.
  • Cardiovascular: Aortic regurgitation, conduction abnormalities, ischemic heart disease risk ↑ 30–50%.
  • Pulmonary: Upper lobe fibrosis, restrictive lung disease from chest wall rigidity.
  • Systemic: Fatigue, low-grade fever, weight loss, night sweats, anemia of chronic disease.

Diagnosis: The Earlier, The Better

Average diagnostic delay: 5–7 years from symptom onset. Why it matters:

  • Early treatment (NSAIDs, biologics) slows radiographic progression.
  • Prevents irreversible structural damage (fusion, kyphosis).
  • Preserves function, work capacity, quality of life.
  • Reduces cardiovascular and osteoporotic complications.

Diagnostic workup: Clinical history + exam (Schober's test, chest expansion, SI joint tenderness) + imaging (X-ray SI joints → MRI if X-ray negative but high suspicion) + labs (HLA-B27 positive in 80–90% Caucasians, less in other groups; CRP/ESR often elevated).

Management Pillars

  • NSAIDs: First-line; continuous use may slow radiographic progression.
  • Biologics (TNF inhibitors, IL-17 inhibitors, JAK inhibitors): For inadequate NSAID response. Transformative for many.
  • Physical Therapy—Daily: Spinal mobility, chest expansion, posture, core strengthening, breathing exercises. Non-negotiable.
  • Exercise: Swimming, yoga, Pilates, axial extension exercises.
  • Smoking cessation: Critical—smoking accelerates spinal fusion, reduces treatment response.
  • Regular rheumatology follow-up: Monitor disease activity (BASDAI, ASDAS), adjust therapy, screen complications.

AS is a lifelong condition, but early, aggressive management changes the trajectory. If you have chronic back pain <45 with inflammatory features—see a rheumatologist. The window to prevent fusion is now.

Sprains - Related Articles